Latest News in the pharma Industry

Research & Development

Cristal Therapeutics progresses nanomedicine CriPec-docetaxel to Phase Ib development

Cristal Therapeutics progresses nanomedicine CriPec-docetaxel to Phase Ib development

1 Nov 2017

This nanomedicine candidate is specifically designed to enable enhanced tumour accumulation and local drug release at the target site, to boost the therapeutic efficacy and to overcome the shortfalls associated with current docetaxel products.

Read more 
FDA approves AstraZeneca's Calquence for adult patients with mantle cell lymphoma

FDA approves AstraZeneca's Calquence for adult patients with mantle cell lymphoma

31 Oct 2017

Accelerated approval of Bruton tyrosine kinase inhibitor in MCL marks AstraZeneca's entry into the treatment of blood cancers.

Read more 
NIH study identifies new targets for anti-malaria drugs

NIH study identifies new targets for anti-malaria drugs

27 Oct 2017

The deadliest malaria parasite needs two proteins to infect red blood cells.

Read more 
First social-health research on the use of seawater in respiratory diseases

First social-health research on the use of seawater in respiratory diseases

25 Oct 2017

7 out of 10 users preferred seawater to traditional serum, claiming it even reduces sick days.

Read more 
Arch Biopartners initiates manufacturing process for Metablok

Arch Biopartners initiates manufacturing process for Metablok

17 Oct 2017

In pre-clinical studies, Metablok has shown it has the ability to prevent acute kidney injury by blocking the inflammatory response triggered by kidney ischemia/reperfusion.

Read more 
SGS and Bavarian Nordic to develop a novel and differentiated challenge model for RSV

SGS and Bavarian Nordic to develop a novel and differentiated challenge model for RSV

13 Oct 2017

Project will build upon the results of Phase II trials undertaken by Bavarian Nordic.

Read more 
PnuVax awarded $29.4 million grant to advance innovative vaccine into clinical trials

PnuVax awarded $29.4 million grant to advance innovative vaccine into clinical trials

2 Oct 2017

Use of PnuVax’s unique patented conjugation platform technology to produce the vaccine is expected to speed up biomanufacturing and increase yield for a greatly reduced per-dose cost.

Read more 
Ardena acquisition will support sponsors with bioanalytical and drug discovery services

Ardena acquisition will support sponsors with bioanalytical and drug discovery services

21 Sep 2017

CDMO on target to become a one-source contract partner for early-phase development.

Read more 
New service delivers streamlined pathway for Phase I trial milestones

New service delivers streamlined pathway for Phase I trial milestones

12 Sep 2017

Whether you're a small, virtual firm or Big Pharma, Recipharm Pathway to Clinic can remove the complexity out of first in human projects.

Read more 
Opdivo + Yervoy combination demonstrated superior overall survival in patients with kidney cancer

Opdivo + Yervoy combination demonstrated superior overall survival in patients with kidney cancer

10 Sep 2017

The combination therapy reduced the risk of death by 37% versus standard of care, sunitinib, in intermediate- and poor-risk patients.

Read more 
Monthly migraine days significantly reduced with erenumab

Monthly migraine days significantly reduced with erenumab

10 Sep 2017

The drug is the first and only fully human monoclonal antibody of its kind, uniquely designed to specifically block the CGRP receptor, which plays a critical role in activation of migraine.

Read more 
Vectura and Pulmatrix sign branded generic tiotropium bromide development agreement

Vectura and Pulmatrix sign branded generic tiotropium bromide development agreement

6 Sep 2017

Major new tiotropium bromide DPI development programme accelerated through licensing of Pulmatrix technology.

Read more